<code id='E2B258E2C8'></code><style id='E2B258E2C8'></style>
    • <acronym id='E2B258E2C8'></acronym>
      <center id='E2B258E2C8'><center id='E2B258E2C8'><tfoot id='E2B258E2C8'></tfoot></center><abbr id='E2B258E2C8'><dir id='E2B258E2C8'><tfoot id='E2B258E2C8'></tfoot><noframes id='E2B258E2C8'>

    • <optgroup id='E2B258E2C8'><strike id='E2B258E2C8'><sup id='E2B258E2C8'></sup></strike><code id='E2B258E2C8'></code></optgroup>
        1. <b id='E2B258E2C8'><label id='E2B258E2C8'><select id='E2B258E2C8'><dt id='E2B258E2C8'><span id='E2B258E2C8'></span></dt></select></label></b><u id='E2B258E2C8'></u>
          <i id='E2B258E2C8'><strike id='E2B258E2C8'><tt id='E2B258E2C8'><pre id='E2B258E2C8'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:entertainment    Page View:48
          People taking notes while sitting around a meeting table
          Adobe

          It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their organizations would see windfalls if those startups hit it big.

          In practice, it often doesn’t work out that way. Doctors and other clinicians have their own way of doing things, and they typically don’t take kindly to an administrator telling them to learn a new product, especially if the goal is financial gain.

          advertisement

          Several health system-venture capital arrangements have fallen victim to this dynamic — but VC firm General Catalyst said this week it will buy nonprofit Summa Health, anyway.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Gene editing the human germline: What are the risks?
          Gene editing the human germline: What are the risks?

          Germlineeditingcanbeusedtorepairadefectivegeneinaspermcell.APStockGeneeditingholdsgreatpromisefortre

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Iowa House, Senate pass 6

          0:22IowaGov.KimReynoldstakespartinapaneldiscussionduringaRepublicanGovernorsAssociationconferenceonN